An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy
With extensive Phase 3 data across diabetes (SUSTAIN trials) and obesity (STEP trials), Semaglutide serves as a benchmark comparator for researchers studying newer metabolic peptides including Tirzepatide and Retatrutide
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
However, the SUSTAIN clinical trials of Ozempic (semaglutide) showed that in addition to blood sugar control, the drug caused weight loss in participants with Type 2 diabetes and obesity
Use the peptide calculator and other tools on SeekPeptides to stay on top of your dosing protocols while implementing these dietary strategies
Better yet, wait 6-8 weeks if you are experiencing fatigue or significant GI symptoms at your current dose
